Talima Therapeutics
San Carlos
About Talima Therapeutics
Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $20.6M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2007)
- Website: talima.com
- Phone: +1 650-331-7246
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/talima-therapeutics-2783202 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.